Pharmacogenomics is reshaping the way therapies are prescribed—connecting inherited genetic differences to how individuals metabolize and respond to common medications. BlazedX PGx panels offer rapid, cost-effective detection of key germline variants using standard qPCR instrumentation.
Designed for versatility and speed, BlazedX PGx panels allow labs to deliver high-impact results without the need for complex NGS workflows. These assays require minimal DNA input and run on widely available 4-channel qPCR platforms, making them an ideal fit for labs expanding their molecular capabilities.
BlazedX PGx assays deliver essential pharmacogenomic insights without the delays and cost of sequencing. Laboratories can now offer actionable results that are both safer and more effective—quickly and reliably.
| Parameter | Specification |
| Input DNA | 1 ng (magnetic bead extraction) |
| Detection Channels | FAM, HEX |
| Reaction Volume | 10 µl |
| Kit Sizes | 48 or 200 samples |
| Platform | 4-channel qPCR, Bio-Rad, ABI |